<DOC>
	<DOCNO>NCT01925534</DOCNO>
	<brief_summary>The purpose study ass whether Optiflow , high-flow humidify oxygen delivery system , superior standard oxygen therapy break noninvasive ventilation patient affect acute respiratory failure respiratory distress . The investigator anticipate Optiflow provide oxygen effectively , comfortable permit long break NIV , shorten total duration NIV .</brief_summary>
	<brief_title>Pilot Study High-flow Humidified Nasal Oxygen During Breaks From Noninvasive Ventilation</brief_title>
	<detailed_description>Background : Noninvasive ventilation ( NIV ) provide respiratory support many patient affect acute respiratory failure . This treatment , compare invasive mechanical ventilation , allow patient take intermittent break oxygen therapy provide nasal cannula mask . During break , lack ventilator support may predispose respiratory distress , retention CO2 oxygen desaturation . Optiflow nasal humidify ( 37◦C , 44mg/L H2O ) high-flow ( 60 L/min ) therapy provide great support standard oxygen therapy break NIV . Aim study evaluate Optiflow alternative standard oxygen therapy break NIV patient acute respiratory failure . The investigator hypothesize tha Optiflow reduce total length stay NIV , increase comfort length break . Also , investigator anticipate reduce respiratory rate , accessory muscle use dyspnea score compare standard oxygen therapy . Experimental design Prospective open-label , parallel , randomize ( 1:1 ) control study , target enrollment 70 . Study procedure Enrolled patient receive NIV randomize two arm ; treatment group receive Optiflow break control arm receive standard oxygen therapy break . In case , FiO2 titrate maintain oxygen saturation 90 % . The necessity break determine together patient ( talk , eat , medication , communicate family , inability tolerate interface ) , need resume NIV base clinical data , dyspnea , respiratory rate , heart rate , blood pressure , oxygen saturation , transcutaneous carbon dioxide ( CO2 ) patient ' desire . Recorded data : The investigator record demographic baseline data ; Glasgow Coma Scale , respiratory heart rate , blood pressure , dyspnea score , accessory muscle use , comfort score randomization , end NIV session NIV break ; length NIV session break ; medication administer arterial blood gas ( ABG ) daily basis . Moreover investigator record NIV parameter inspire oxygen fraction ( FiO2 ) session break . Risks : The investigator n't anticipate significant risk relate study procedure equipment . Some patient may tolerate Optiflow patient may fail NIV require intubation .</detailed_description>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<criteria>Patients 18 year age treat Bipap CPAP per hospital protocol , underlie clinical diagnosis acute respiratory failure . Patients , prior administration NIV , persistent respiratory acidosis pH &lt; 7.35 arterial CO2 &gt; 45 mmHg despite controlled oxygen therapy standard medical management i.e . bronchodilator , corticosteroid antibiotic , Patients hypoxemic respiratory failure PaO2/FiO2 ratio &lt; 300 respiratory rate ≥ 24 . Anticipated duration NIV least 24 hrs Exclusion criterion : Usual contraindication NIV Respiratory arrest Unable fit mask Medically unstable multiple organ failure unstable coronary disease Agitated uncooperative Unable protect airway Swallowing difficulty Excessive secretion manage clearance technique Recent upper airway gastrointestinal surgery Facial deformity previous head neck surgery Undrained pneumothorax NIV failure within first 2 hour ( either intolerance requirement intubation ) Managed great 48 hour NIV prior randomization Disorientation , confusion , unable rate comfort dyspnea Expected require NIV few 24 hr time enrollment Patient previously study Patients CPAP nighttime due OSA Withdrawal/Termination criterion : Patients withdraw study NIV fail and/or patient intubate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Optiflow</keyword>
	<keyword>Humidified high-flow oxygen therapy</keyword>
	<keyword>Noninvasive ventilation</keyword>
	<keyword>Acute respiratory failure</keyword>
	<keyword>Standard oxygen therapy</keyword>
</DOC>